Pediatric Acute Leukemia (PedAL) Screening Trial - Developing New Therapies for Relapsed Leukemias
Sponsor: |
Children's Oncology Group |
Enrolling: |
Male and Female Patients |
IRB Number: |
AAAU0227 |
U.S. Govt. ID: |
NCT04726241 |
Contact: |
Nobuko Hijiya: 212-305-9770 / nh2636@cumc.columbia.edu |
This study is called a screening study and the purpose of this study to find better ways to diagnose and treat leukemia that has come back after treatment or difficult to treat. Bone marrow, blood, and medical information about cancer and treatment will be collected. The results from this screening study may give other information about leukemia that is important when deciding how to best treat leukemia.
This study is closed
Investigator
Nobuko Hijiya, MD
Are you, or your child, under the age of 22? |
Yes |
No |
Have you, or your child, been diagnosed with relapsed leukemia? |
Yes |
No |